AI Recipe Generator
Can’t figure out what to cook? Take a look in your fridge, pick a few ingredients, and plug them into our AI…
Comprehensive Medical Weight Loss
Expert Advice and Updates on Medical Weight Loss
AMA Elevates Obesity as a Public Health Priority
Thirteen years ago, the AMA launched a strategic plan with three primary objectives, one of which was improving health outcomes related to…
Coaching Helps GLP-1 Medications Work Better for Weight Loss
GLP-1 medications like semaglutide and tirzepatide can help people lose 15–25% of their body weight over 1–2 years. But like medicine for…
How High-Quality Carbs in Midlife Can Help You Age Well
As women move through their 40s and 50s, many start thinking more seriously about their long-term health—and for good reason. A new…
Does the Order We Eat Our Food Matter? New Insights from the Obesity Medicine Conference
I recently had the opportunity to attend and speak at the Obesity Medicine Association’s annual conference. It was inspiring to be surrounded…
Are Older Weight Loss Medications Still Useful?
These days, there’s a lot of buzz around the new injectable weight loss medications. Wegovy® and Zepbound™ are making headlines because they…
Successful Weight Loss: Calorie control vs. Hunger control
For decades, people have been told that to lose weight, one must eat less and move more. This age-old adage is about…
Introducing CNC e-Visits – Convenient, High-Quality Care at Your Fingertips!
We’re excited to introduce CNC e-Visits, a new way to connect with your provider for quick, efficient, and high-quality care—without the need…
How Working with a Registered Dietitian Nutritionist (RDN) Can Enhance GLP-1 Effectiveness for Weight Loss
GLP-1 medications like semaglutide and tirzepatide have revolutionized obesity treatment, helping patients achieve 10%-25% weight loss over one to two years. However,…
New Options for Wegovy and Zepbound
Wegovy: $499 / Month || Zepbound: $499 / Month As both Wegovy (semaglutide) and Zepbound (tirzepatide) are coming out of shortage, both…
